Integrated Applications Promotion

Global Point-of-Care Glucose Testing Market Report 2023: Sector is Expected to Reach $4.51 Billion by 2030 at a CAGR of 4.1% - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 6, 2023
Health, Diabetes, Silver, Diagnosis, Platinum, POCT, Carbohydrate metabolism, Integrated Applications Promotion, Gold, Point-of-care testing, Skin, USD, Medical device

The global point-of-care glucose testing market size is expected to reach USD 4.51 billion by 2030, registering a CAGR of 4.1% over the forecast period.

Key Points: 
  • The global point-of-care glucose testing market size is expected to reach USD 4.51 billion by 2030, registering a CAGR of 4.1% over the forecast period.
  • An increase in the demand for Point-of-Care Testing (POCT) has been witnessed in recent years.
  • As compared to the conventional laboratory testing performed in central lab settings, glucose POCT aids in performing effective diagnosis at the patient's bedside.
  • Eversense, painless glucose monitoring subcutaneous implant by Senseonics, quantifies glucose levels in interstitial fluid when placed beneath the skin.

SatixFy's Fully Digital Beam-Hopping Payload Successfully Launched on OneWeb's JoeySat Satellite

Retrieved on: 
Monday, May 22, 2023
Telecommunications, Satellite, Internet, Technology, IOT (Internet of Things), Aerospace, Manufacturing, Mobile, Wireless, Integrated Applications Promotion, Australian Space Agency, Communication, ESA, Sunrise, OneWeb, Orbit, UK Space Agency, SATX, European Space Agency, Government, Ecosystem, NYSE, Energy Transitions Initiative Partnership Project, Software, Communications satellite, Renewable energy

SatixFy Communications Ltd. (“SatixFy”) (NYSE AMERICAN: SATX), a leader in next-generation satellite communication systems based on in-house-developed chipsets, announced today that the OneWeb JoeySat Satellite was successfully launched from California on Saturday, May 20, 2023.

Key Points: 
  • SatixFy Communications Ltd. (“SatixFy”) (NYSE AMERICAN: SATX), a leader in next-generation satellite communication systems based on in-house-developed chipsets, announced today that the OneWeb JoeySat Satellite was successfully launched from California on Saturday, May 20, 2023.
  • This advanced broadband satellite, designed to offer high-speed internet connectivity anywhere on Earth, has been nicknamed ‘JoeySat’ after a baby kangaroo for its beam-hopping abilities.
  • Its fully digital beam-hopping and beam-steering payload, provided by SatixFy, can switch between various places on Earth up to 1000 times per second and adjust the strength of the communications signals to meet demand.
  • Its advanced digital regenerative payload was built, tested and fully qualified by SatixFy.

Inmarsat: Greener Flights Coming to Italy Soon as ITA Airways to Join Iris Air Traffic Modernisation Programme

Retrieved on: 
Thursday, March 9, 2023
Environment, Technology, Air, Environmental Issues, Transport, Software, Alternative Energy, Green Technology, Networks, Energy, Aircraft, Air navigation service provider, Airbus A330neo, Single European Sky ATM Research, Air traffic management, News, ANSP, Integrated Applications Promotion, Australian Space Agency, CO2, Airbus A320neo family, EUROCONTROL, Estonian Air Navigation Services, Single European Sky, European Space Agency, Inmarsat, Partnership, Atmosphere, VHF, ITA Airways, Transavia, ATM, Airbus, Aviation, LCS, ESA, EasyJet, SESAR, Airline, Telecommunications, Iris, Safety

ITA Airways will be the first full service carrier in Europe to join Iris.

Key Points: 
  • ITA Airways will be the first full service carrier in Europe to join Iris.
  • Without fast and reliable data links between aircraft and the ground, air traffic managers cannot unlock the 8-10% reduction in CO2 emissions identified by EUROCONTROL from improved Air Traffic Management (ATM).
  • Current SB-S users include Virgin Atlantic, Jet2, and Transavia Airlines, in addition to ITA Airways and easyJet.
  • We are proud to join the Iris programme, which is fully in line with our growth strategy as it reflects two of the core pillars of ITA Airways: sustainability and innovation.

Sumaria Systems announces appointment of Dave Dzaran as the company's Chief Executive Officer (CEO)

Retrieved on: 
Tuesday, January 31, 2023
Unitary state, Retirement, Government, Engineering, Culture, Integrated Applications Promotion, NRO, Air force, Intelligence, Growth, ISR, USAF, National Reconnaissance Office, Management, Centauri

WASHINGTON, Jan. 31, 2023 /PRNewswire/ -- Sumaria Systems, a leading provider of professional, technology, engineering, and management services to the U.S. Government, has announced the appointment of Dave Dzaran to Chief Executive Officer (CEO).

Key Points: 
  • WASHINGTON, Jan. 31, 2023 /PRNewswire/ -- Sumaria Systems, a leading provider of professional, technology, engineering, and management services to the U.S. Government, has announced the appointment of Dave Dzaran to Chief Executive Officer (CEO).
  • As CEO, Dave will oversee the continued growth of the company and sustain the strong culture built on performance, teamwork and commitment to its customers, partners, and employees.
  • Before joining Sumaria, Dave served most recently as a Deputy Program Director at the National Reconnaissance Office (NRO).
  • "Dave is a proven leader with over 38 years of executive leadership experience working in sensor and spacecraft design, system engineering, development, integration, and testing."

GLUCOTRACK ANNOUNCES THE HIRING OF DR. MARK TAPSAK

Retrieved on: 
Friday, October 14, 2022
Cloud, News, Biochemistry, U.S. Securities and Exchange Commission, Miniature Sensor Technology Integration-3, SEC, Technology, Annual report, NASDAQ, Lists of schools in England, Bloomsburg University of Pennsylvania, Patient, Dexcom, Research, St. Cloud State University, Publication, Medtronic, Â, Risk, Nasdaq, Naval Photographic Science Laboratory, University, Integrated Applications Promotion, Solution, Private Securities Litigation Reform Act, CGM, Company, Doctor of Philosophy, Industry, Health, Dean, CEO, Sponsor, Pain, Prediabetes, Diabetes, GLOBE, Diabetes Health Profile, Intellectual property, ISCB Senior Scientist Award, FDA, Freedom, School Health Education Study, Medical device, Chemistry, Science

Rutherford, NJ, Oct. 14, 2022 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device and digital health platform company focused on diabetes and prediabetes, announced today that Mark Tapsak, PhD, has joined the Company as Vice President of Sensor Technology, effective immediately.

Key Points: 
  • Mark brings over 25 years of experience in the diabetes industry as a medical device research scientist, focused on polymer synthesis, polymer characterization, medical device design and intellectual property.
  • Mark joinsthe Companyfrom Diabetic Health, Inc., a developer of specialty coatings utilized in continuous glucose monitoring sensors and insulin infusion sets, where he served as President.
  • Mark and I worked together in the early days of development at DexCom, and I am thrilled to be working with him again, said Paul Goode, CEO and President of GlucoTrack.
  • GlucoTracks approach to advancing solutions for the management of diabetes and prediabetes is both unique and innovative, said Dr. Tapsak.

GLUCOTRACK ANNOUNCES THE HIRING OF DR. MARK TAPSAK

Retrieved on: 
Friday, October 14, 2022
Cloud, News, Biochemistry, U.S. Securities and Exchange Commission, Miniature Sensor Technology Integration-3, SEC, Technology, Annual report, NASDAQ, Lists of schools in England, Bloomsburg University of Pennsylvania, Patient, Dexcom, Research, St. Cloud State University, Publication, Medtronic, Â, Risk, Nasdaq, Naval Photographic Science Laboratory, University, Integrated Applications Promotion, Solution, Private Securities Litigation Reform Act, CGM, Company, Doctor of Philosophy, Industry, Health, Dean, CEO, Sponsor, Pain, Prediabetes, Diabetes, GLOBE, Diabetes Health Profile, Intellectual property, ISCB Senior Scientist Award, FDA, Freedom, School Health Education Study, Medical device, Chemistry, Science

Rutherford, NJ, Oct. 14, 2022 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device and digital health platform company focused on diabetes and prediabetes, announced today that Mark Tapsak, PhD, has joined the Company as Vice President of Sensor Technology, effective immediately.

Key Points: 
  • Mark brings over 25 years of experience in the diabetes industry as a medical device research scientist, focused on polymer synthesis, polymer characterization, medical device design and intellectual property.
  • Mark joinsthe Companyfrom Diabetic Health, Inc., a developer of specialty coatings utilized in continuous glucose monitoring sensors and insulin infusion sets, where he served as President.
  • Mark and I worked together in the early days of development at DexCom, and I am thrilled to be working with him again, said Paul Goode, CEO and President of GlucoTrack.
  • GlucoTracks approach to advancing solutions for the management of diabetes and prediabetes is both unique and innovative, said Dr. Tapsak.

GLUCOTRACK TO BEGIN RESEARCH & DEVELOPMENT OF NOVEL CONTINUOUS GLUCOSE MONITORING SYSTEM

Retrieved on: 
Monday, October 10, 2022
News, U.S. Securities and Exchange Commission, SEC, Annual report, NASDAQ, Patient, Nasdaq, Technology, Integrated Applications Promotion, Private Securities Litigation Reform Act, Company, Acquisition, CEO, Pain, IP, Prediabetes, Type 1, Type 2 diabetes, Diabetes, GLOBE, FDA, Risk, Medical device, Pharmaceutical industry

Following the recent acquisition of certain related IP, the Company intends to develop a long-term implantable glucose management technology to address the growing Type 1 diabetes market.

Key Points: 
  • Following the recent acquisition of certain related IP, the Company intends to develop a long-term implantable glucose management technology to address the growing Type 1 diabetes market.
  • In addition, as reported earlier this year, the Company completed lab testing of its non-invasive GlucoTrack 2.0 clinical prototype system and observed better-than-expected accuracy and performance with the technology.
  • GlucoTrack, Inc. (NASDAQ: GCTK), (formerly known as Integrity Applications, Inc.) is focused on the design, development, and commercialization of non-invasive glucose monitoring technologies for people with diabetes and prediabetes.
  • The Companys initial product, GlucoTrack, is a proprietary non-invasive glucose monitoring device designed to obtain glucose level measurements without the pain, incremental cost, difficulty, or discomfort of conventional invasive finger stick devices.

CAES Wins Contracts for Development of Next-Generation, Octa-Core, User-Selectable CPU for Space

Retrieved on: 
Thursday, September 22, 2022
Data Management, Aerospace, Technology, Manufacturing, Semiconductor, Satellite, Telecommunications, Government Technology, Defense, Contracts, Engineering, International Astronautical Congress, Software, RF, Electronics, Intelligence Advanced Research Projects Activity, Radiation, TDE, STMicroelectronics, Space segment, CPU, Research, LEON, Contract, Senior, Swedish National Space Agency, Industry, SPARC, ARTES, The Digital Group, Program, SEU, SOC, European Space Agency, Technology, Defense, SNSA, ST, Architecture, Silicon, General manager, Â, Australian Space Agency, ESA, Multimedia, Atmosphere, Swap, Space and Missile Systems Center, IAC, Integrated Applications Promotion, Video game console, Mobile phone, Telecommunication, CAES

View the full release here: https://www.businesswire.com/news/home/20220922005814/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220922005814/en/
    CAES announced that it has won multiple contracts with the European Space Agency (ESA) for the development of the GR765 System-on-Chip (SOC), the first user selectable CPU for space.
  • (Photo: Business Wire)
    CAES previously received funding from the Swedish National Space Agency (SNSA) within ESAs General Support Technology Program (GSTP) for the preliminary GR765 system requirement development.
  • The new incremental Advanced Research in Telecommunications Systems (ARTES) and Technology Development Element (TDE) program contracts will enable CAES to move forward with the GR765 prototype development and manufacturing on this technology.
  • Core Competitiveness is dedicated to the development, qualification and demonstration of products (Competitiveness and Growth), or long-term technology development (Advanced Technology).

SES, ESA and European Commission Partnering to Deliver Satellite Quantum Cryptography System for European Cybersecurity

Retrieved on: 
Thursday, September 22, 2022
Technology, Internet, Security, Satellite, Luxembourg government in exile, Czech Republic, QCI, European Commission, Partnership, Industry, ARTES, European Space Agency, CEO, Technology, Solution, QKD, SES, Australian Space Agency, ESA, Royal commission, Union, Multimedia, LEO, Integrated Applications Promotion, Communications satellite, Cryptocurrency, Renewable energy, EU, Telecommunication

An SES-led consortium of 20 European companies, with the European Space Agency (ESA) and European Commission support, will design, develop, launch and operate the EAGLE-1 satellite-based end-to-end system for secure Quantum Key Distribution (QKD), enabling in-orbit validation and demonstration of next-generation cyber-security across Europe.

Key Points: 
  • An SES-led consortium of 20 European companies, with the European Space Agency (ESA) and European Commission support, will design, develop, launch and operate the EAGLE-1 satellite-based end-to-end system for secure Quantum Key Distribution (QKD), enabling in-orbit validation and demonstration of next-generation cyber-security across Europe.
  • View the full release here: https://www.businesswire.com/news/home/20220922005427/en/
    SES, ESA and European Commission Partnering to Deliver Satellite Quantum Cryptography System for European Cybersecurity (Graphic: Business Wire)
    The groundbreaking partnership between ESA and an SES-led consortium, with the European Commission support, is advancing Europe to the front of space innovation with satellite-enabled QKD.
  • The EAGLE-1 satellite is due to launch in 2024 and will then complete three years of in-orbit mission supported by the European Commission.
  • Led by ESA, partially financed by the European Commission and implemented by SES, EAGLE-1 is a major step towards making the secure and scalable European Quantum Communications Infrastructure a reality.

GlucoTrack, Inc. Provides Development Update on its Gen 2 Non-Invasive Glucose Monitor

Retrieved on: 
Wednesday, June 22, 2022
Pacific Northwest Diabetes Research Institute, Ethics committee, FDA, Type 2 diabetes, Annual report, Focus, CEO, Electronics, Company, U.S. Securities and Exchange Commission, Trial of the century, Continuous glucose monitor, Private Securities Litigation Reform Act, Prediabetes, Radio-frequency identification, Pain, GLOBE, Integrated Applications Promotion, Medical director, NASDAQ, News, SEC, Nasdaq, Patient, Rabin Medical Center, Risk, Medical device

In early Q2 the Company completed lab testing of its Gen 2 clinical prototype system.

Key Points: 
  • In early Q2 the Company completed lab testing of its Gen 2 clinical prototype system.
  • This process included testing of multiple iterations of electronics, ear clip, and mobile app with cloud-based software.
  • The completion of bench testing and analyses of the Gen 2 clinical prototype system was followed by simulated use testing.
  • Initial data collected indicates that the Gen 2 system may achieve an accuracy comparable to invasive Continuous Glucose Monitors (CGMs) currently available in the market when conducting the upcoming first in-human clinical study.